MeSH Browser

MeSH Supplementary: TCCSG B-8801 protocol
Unique ID: C075752
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C075752
Entry Term(s): Tokyo Children's Cancer Study Group B-8801 protocol
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hydrocortisone; Methotrexate; Prednisolone
Frequency: 2
Note: chemotherapy protocol consisting of above cpds; has 3 variations (Blocks); Block1 also contains cytarabine, Block2 also contains cytarabine, vincristine & enocytabine. Block3 also contains vincristine; used for treatment of B-cell-type lymphoma associated with Bloom's syndrome
Source: Clin Genet 1992 Jan;41(1):46-50
Date of Entry: 1992/08/20
Revision Date: 2003/01/29

TCCSG B-8801 protocol MeSH Supplementary Concept Data 2024